This article was published on NewsNationNow.com. Watch NewsNation on WGN America and download the NewsNation Now app.

Click on the link below to see the full story. 

Thursday afternoon, the U.S. Food and Drug Administration’s panel of outside advisors voted the Pfizer COVID-19 vaccine benefits outweigh its risk for use in individuals 16 years of age and older, effectively endorsing Pfizer’s coronavirus vaccine for emergency use authorization approval in the United States. Read More

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.